A coupled peroxidatic oxidation technique for the histochemical localization of monoamine oxidase A and B and benzylamine oxidase. 1979

T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler

A coupled peroxidatic oxidation technique is presented which employs benzylamine and tyramine as substrates and clorgyline, deprenyl, phenelzine and pargyline as specific inhibitors. Using this technique with frozen sections of human term placenta and rat liver, the histochemical localization of monocamine oxidase A and B and bnezylamine oxidase has been demonstrated.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001595 Benzylamine Oxidase An aspect of monoamine oxidase, EC 1.4.3.4. Catalyzes the oxidation of benzylamine to form benzaldehyde, ammonia and hydrogen peroxide. Clorgyline-Resistant Amine Oxidase,Amine Oxidase, Clorgyline-Resistant,Clorgyline Resistant Amine Oxidase,Oxidase, Benzylamine,Oxidase, Clorgyline-Resistant Amine

Related Publications

T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
January 1965, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
October 1986, Endocrinology,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
May 1980, Biochemical pharmacology,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
December 1985, The Histochemical journal,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
February 1973, Rinsho byori. The Japanese journal of clinical pathology,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
June 1994, Biochemistry,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
January 1978, Biochemical pharmacology,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
January 1989, Neuroscience,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
March 1991, FEBS letters,
T A Ryder, and M L MacKenzie, and J Pryse-Davies, and V Glover, and R Lewinsohn, and M Sandler
December 1954, The Journal of physiology,
Copied contents to your clipboard!